Friday, 03 November, 2023
14.00 – 19.00
Registration
17.00 – 17.30
Official opening
Chairs: Elissaveta Naumova, Dominique Charron, Gottfried Fisher
17.30 – 19.00
Keynote Session
Transplant Immunogenetics in 21st century - Dominique Charron (France)
Transplant Immunology in Bulgaria – history, achievements, and vision for the future – Elissaveta Naumova (Bulgaria)
(Saturday), 04 November, 2023
08.00 – 12.00
Registration
8.30 – 10.00
SESSION 1 - New aspects in transplantation
Moderators:Catherine Stavropoulos-Giokas, Gottfried Fisher
Cord Blood Bank in the 21st Century. Reality and challenges – Catherine Stavropoulos-Giokas (Greece)
Adult allogeneic hematopoietic stem cell transplantation activity in specialized hospital for active treatment of hematological diseases –
Georgi Mihaylov, Kameliya Milcheva, Krasen Venkov, Penka Ganeva,Victoriya Nikolova-Yankova, Ivan Tonev, Stanislav Simeonov, Milcho Minchev, Galya Kondeva (Bulgaria)
Kidney transplantation in Bulgaria - past and present -
Мetodi Milushev, Vladislav Mladenov, Krassimir Yanev, Marincho Georgiev (Bulgaria)
Liver transplantation in Bulgaria -
Vassil Mihaylov (Bulgaria)
Xenotransplantation: past, present, and future –
Katerina Tarassi (Greece)
10.00 – 10.30 Coffee Break
10.30 – 11.50
SESSION 2 - Current challenges in H&I
Moderators: Milena Ivanova, Dominique Charron
Challenges for HLA antibody screening and identification – Gottfried Fisher (Austria)
DPw antibodies in kidney transplantation – Blanka Vidan Jeras (Slovenia)
The Armenian Bone Marrow Donor Registry: a catalyst for life-saving transplantation in Armenia and beyond - Frida Jordan (Armenia)
Antibodies to non-HLA antigens and their significance in transplant reactions – Antonij Slavchev (Czech Republic)
11.50 – 13.00 | Industry Symposia
13.00 – 14.00 Lunch and Poster viewing
14.00 – 16.00
SESSION 3 - Selected oral presentations
Moderators: Frida Jordan, Katarzyna Bogunia-Kubik, Antonij Slavchev
O-01 En route to the promised land: challenges in anti HLA antibody testing in Israel – Moshe Israeli, Hagar Ben-Ari, Yasmin Nasser, Abigail Rozengarten (Israel)
O-02 T lymphocyte subsets in long-term kidney transplant survivors – Asimina Fylaktou, Efstratios Kasimatis, Grigorios Myserlis, Aliki Xochelli, Lampos Vagiotas, Georgios Lioulios, Vasiliki Nikolaidou, Maria Stangou, Georgios Tsoulfas (Greece)
Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients in Greece – Angeliki Vittoraki, Stathis Tsiakas, Eleni Stergiopoulou, Alexandra Siorenta, Sofia Ioannou, Athina- Aikaterini Nikolaou, Chrysanthi Tsirligkani, Maria Darema, Smaragdi Marinaki, Georgios Paterakis, John N.Boletis (Greece)
O-04 Comparison of C1q binding and flow cytometric crossmatch results provides an accurate evaluation of high risk, hypersensitive kidney transplant patients – Emel Eksioglu-Demiralp, Serpil Gorcin, Onur Elbasi, Aydin Turkmen (Turkiye)
O-05 The effect of epitope mismatches on haploidentical haematopoietic stem cell transplantation – Yeliz Ogret, Ipek Yonal Hindilerden, Behnoush Nasr Zanjani, Tarık Onur Tiryaki, Demet Izgi, Efe Akce, Sıla Basak Gok, Cigdem Kekik Cinar, Meliha Nalcaci, Fatma Savran Oguz (Turkiye)
O-06 The association of HLA class I and class II polymorphisms with malignant hemopathies in Serbian patients – – Kačaki Nikola, Blagojević Glorija, Jovanović Barbara, Miladinović Željka, Andrić Zorana (Serbia)
O-07 T-cell clonality assessment by flow cytometry using anti-TCR-Cb-1: initial experience of a single center – Vladimirova Rositsa, Muhtarova Maria, Jagurinoski Milan, Vasilev Georgi, Balatzenko Gueorgui, Guenova Margarita (Bulgaria)
O-08 KIR and NK cell subsets profiles in patients with reproductive failure – Snezhina Mihailova, Spaska Lesichkova, Anastasiya Mihaylova, Antoaneta Nedyalkova, Alexandar Kalchev, Elissaveta Naumova (Bulgaria)
O-09 The role and diagnostic significance of HLA-DQ typing in suspected gluten intolerance – Olgica Sibinovska, Meri Kirijas, Gorjan Milanovski, Teodora Brnjarchevska – Blazevska, Tamara Savevska, Kristina Stamatovska, Sanja Kicevska, Stefani Iljoska, Olivija Efinska - Mladenovska, Aleksandar Petlichkovski (Macedonia)
O-10 Profile of anti-HLA antibodies in kidney recipients – a single center study – Daniela Constantinescu, Corina Cianga, Mariana Pavel-Tanasă, Camelia Mihăilă, Sebastian Harnău, Petru Cianga (Romania)
O-11 Immune-mediated complications after haploidentical stem cell transplantation. Clinical case – Yavor Petrov, Vladimr Gerov, Ilina Micheva (Bulgaria)
16.00 – 16.30 | Refreshment Break
16.30 – 18.00
SESSION 4 - EFI and EPT affaires
Moderators: Blanka Vidan Jeras, Ingrid Fae, Katerina Tarassi
EFI Accreditation Programme – update - Blanka Vidan Jeras (Slovenia)
CET EPT Program – Ingrid Fae (Austria)
EFI EPT Programs within Region 5 – current activity and further perspectives of collaboration with EFI EPT Region 8- Katarzyna Bogunia-Kubik (Poland)
Commissioner report EFI Region 8A and 8B – Katerina Tarassi (Greece), Nina Svetlitzky (Israel)
Balkan EPT results for HLA typing schemes in 2023 – Fatma Oguz (Turkiye)
Balkan EPT results for alloantibodies, crossmatch and HLA-B27 schemes in 2023 – Anastasia Mihaylova (Bulgaria), Fatma Oguz (Turkiye)
18.00 | Best Poster award and closing of the conference
20.00 | Network Event - Shakespeare Hall
POSTERS
P-01 | HLA-C*06:02 and DRB3*01:01 might indicate a good response to Pfizer-BioNTech anti-SARS-COV-2 vaccine.Genovefa Chronopoulou, Anastasia Pangalis, Nikolaos Moussas, Jamie L Duke, Amalia Dinou, Efstathios Michalopoulos, Theofanis K Chatzistamatiou, Panagiotis Gargalianos, Dimitri S Monos, Catherine Stavropoulos-Giokas (Greece)
P-02 | Investigating the Relationship Between KIR Receptor Genotypes and Symptom Severity in SARS-CoV-2 Infected Patients. Sonay Temurhan, Yeliz Ogret, Demet Kivanc, Behnous Nasr Zanjani, Fatma Betul Oktelik, Fatma Savran Oguz, Murat Kose, Gunnur Deniz, Cigdem Kekik Cinar (Turkiye)
P-03 | Investigating associations between HLA-A, HLA-B and HLA-C allele Polymorphisms, H.pylori infection, and anti-CagA IgA among Turkish gastritis patients. Lokman Karataş, Mukaddes Colakogullari (Turkiye)
P-04 | Expression of angiopoietin on the kidney transplant waiting list: a single center study. Suleyman Rustu Oguz, Ayse Sinangil, Demet Kivanc Izgi, Soykan Barlas, Hayriye Senturk Ciftci, Kıymet Guzin Sen, Tevfik Ecder, Baris Akin (Turkiye)
P-05 | The effect of sensitisation history on panel reactive antibody and single antigen bead in CKD patients on the transplant waiting list. Demet Kivanc Izgi, Hayriye Senturk Ciftci, Cigdem Kekik Cinar, Fatma Savran Oguz (Turkiye)
P-06 | Alterations of T lymphocytes subpopulations post successful renal transplantation. Asimina Fylaktou, Lampos Vagiotas, Aliki Xochelli, Georgios Lioulios, Efstratios Kasimatis, Vasiliki Nikolaidou, Maria Stangou, Georgios Tsoulfas (Greece)
P-07 | Comparison of two NGS-based methods for high-resolution HLA typing. Bozhidara Shtereva, Maria Teneva, Trifon Chervenkov (Bulgaria)
P-08 | Bulgarian Bone Marrow Donor Registry - current status. Angelina Mladenova, Tsvetelin Lukanov, Daniela Marinova, Elissaveta Naumova (Bulgaria)
P-09 | The potential of a prospective HLA haplobank of the Bulgarian population. Valentina Atanasova, Anastasiya Mihaylova, Bushra Al Hadra, Milena Ivanova, Elissaveta Naumova (Bulgaria)
P-10 | Post-transplant Chimerism monitoring - real-time qPCR or STR? Adriana Kaleva, Tsvetelin Lukanov, Elissaveta Naumova (Bulgaria)
P-11 | The retrospective analysis of screened and detailed complement-dependent cytotoxicity test results. Salih Haldun Bal, Onur Etgü, Mert Karaca, Muhammed Ali Kızmaz, Abdurrahman Şimşek, Figen Aymak, Ferah Budak, Haluk Barbaros Oral (Turkiye)
P-12 | Cytomegalovirus antibody positivity and Human Leukocyte Antigen relationship in patients in the cadaver waiting list. Hayriye Şentürk Çiftçi, Hüseyin Bakkaloğlu, Adem Bayraktar, Çiğdem Kekik Çınar, Ekin Ece Gürer, Demet Kıvanç Izgi, Mediha Süleymanoğlu, Ayşe Erol, Ali Emin Aydın, Fatma Savran Oğuz (Turkiye)
P-13 | HLA-A,-B,-C,-DRB1,-DQB1 allele frequency in renal transplant patients with a diagnosis of COVID-19. Hayriye Senturk Ciftci, Erol Demir, Mediha Süleymanoglu, Nurana Garayeva, Ayse Serra Artan, Ciğdem Kekik Cinar, Huseyin Bakkaloglu, Tzevat Tefik, Meltem Savran Karadeniz, Demet Kivanc Izgi, Yeliz Ogret, Ayse Erol, Aydın Turkmen, Ismet Nane, Ali Emin Aydin, Fatma Savran Oguz (Turkiye)
P-14 | Cytokine changes in vitro treatment of colorectal cancer cells with human umbilical cord blood-derived mesenchymal stem cells. Figen Abatay Sel, Ayşe Erol, Mediha Süleymanoğlu, Ayşe Büşra Önder, Dürdane Serap Kuruca, Fatma Savran Oğuz (Turkiye)
P-15 | HLA allele frequencies of individuals who applied to Erciyes University tissue typing laboratory. Öznur Korkmaz, Rabiya Nayir, Çağman Tan, Mustafa Yavuz Köker (Turkiye)
P-16 | Long-term survival in a heart and kidney transplant recipient: A case report. . Petya Yankova, Emil Paskalev, Krassimir Yanev, Nezabravka Chilingirova, Elissaveta Naumova (Bulgaria)
P-17 | Relationship between severity and clinical outcomes of disease due to SARS-CoV-2 infection and circulating markers of netosis or pyroptotic cell death. disease due to SARS-CoV-2 infection and circulating markers of netosis or pyroptotic cell death. Yeliz Duvarci Ogret, Ayse Seda Akdemir, Seydanur Dogan , Selen Zeliha Mart Komurcu , Merve Damla Korkmaz , Ebru Kaya , Sevim Yavas , Ahmet Derican , Selçuk Dasdemir , Melek Ozturk (Turkiye)
P-18 | Discovery of three novel HLA alleles by Next Generation Sequencing in Greek population.Diamanto Kouniaki, Katerina Tarassi, Vassiliki Kitsiou, Theofilos Athanassiades, Konstantinos
Fotopoulos, Ioannis Karatas, Vaia Stamati, Alexandra Tsirogianni. (Greece)